OUR RESOURCES

Rare Malignancies

Rare Malignancies - Day 1 - 2 March 2023

Welcome & Introduction

How I Treat ES-SCLC with Durvalamb-Real world experience

Optimizing Treatment Decisions in Unresectable Stage-III NSCLC-A Case Study

Medical Oncology-Neuroendocrine Tumors in the Lung

Pathology-Neuroendocrine tumors in the lung

Nuclear Medicine-Diagnosis and Therapeutic Aspects

Case Based Panel Discussion

Expert Comment

Closing remarks

Optimizing Treatment Decisions in Unresectable Stage-III NSCLC-A Case Study

Medical Oncology-Neuroendocrine Tumors in the Lung

Nuclear Medicine-Diagnosis and Therapeutic Aspects